Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

mAbs

Showing results (251-260 of 1,833) with videos related to

Pageof 184
Sort By:
Mabs|January 5, 2018
Antibodies to watch in 2018Hélène Kaplon, Janice M Reichert
Mabs|September 5, 2020
Biophysical and biochemical characterization of a VHH-based IgG-like bi- and trispecific antibody platformLukas Pekar, Michael Busch, Bernhard Valldorf, et al.
Mabs|November 4, 2020
Fully human anti-CD39 antibody potently inhibits ATPase activity in cancer cells via uncompetitive allosteric mechanismBradley N Spatola, Alana G Lerner, Clifford Wong, et al.
Mabs|November 5, 2020
Vaccine-induced CD8 T cells are redirected with peptide-MHC class I-IgG antibody fusion proteins to eliminate tumor cells in vivoCornelia Fischer, Michael W Munks, Ann B Hill, et al.
Mabs|January 11, 2023
HDX-MS study on garadacimab binding to activated FXII reveals potential binding interfaces through differential solvent exposureSaw Yen Ow, Eugene A Kapp, Vesna Tomasetig, et al.
Mabs|January 11, 2023
Approaches to expand the conventional toolbox for discovery and selection of antibodies with drug-like physicochemical propertiesHristo L Svilenov, Paolo Arosio, Tim Menzen, et al.
Mabs|January 22, 2023
Toward generalizable prediction of antibody thermostability using machine learning on sequence and structure featuresAmeya Harmalkar, Roshan Rao, Yuxuan Richard Xie, et al.
Mabs|November 23, 2022
Non-human primates in the PKPD evaluation of biologics: Needs and options to reduce, refine, and replace. A BioSafe White PaperKarelle Ménochet, Hongbin Yu, Bonnie Wang, et al.
Mabs|June 7, 2021
A human antibody of potent efficacy against SARS-CoV-2 in rhesus macaques showed strong blocking activity to B.1.351Chunyin Gu, Xiaodan Cao, Zongda Wang, et al.
Mabs|November 30, 2022
A glyco-engineering approach for site-specific conjugation to Fab glycansMaria L Jaramillo, Traian Sulea, Yves Durocher, et al.
Pageof 184

Showing results (251-260 of 1,833) with videos related to

Sort By:
Pageof 184
Mabs|January 5, 2018
Antibodies to watch in 2018Hélène Kaplon, Janice M Reichert
Mabs|September 5, 2020
Biophysical and biochemical characterization of a VHH-based IgG-like bi- and trispecific antibody platformLukas Pekar, Michael Busch, Bernhard Valldorf, et al.
Mabs|November 4, 2020
Fully human anti-CD39 antibody potently inhibits ATPase activity in cancer cells via uncompetitive allosteric mechanismBradley N Spatola, Alana G Lerner, Clifford Wong, et al.
Mabs|November 5, 2020
Vaccine-induced CD8 T cells are redirected with peptide-MHC class I-IgG antibody fusion proteins to eliminate tumor cells in vivoCornelia Fischer, Michael W Munks, Ann B Hill, et al.
Mabs|January 11, 2023
HDX-MS study on garadacimab binding to activated FXII reveals potential binding interfaces through differential solvent exposureSaw Yen Ow, Eugene A Kapp, Vesna Tomasetig, et al.
Mabs|January 11, 2023
Approaches to expand the conventional toolbox for discovery and selection of antibodies with drug-like physicochemical propertiesHristo L Svilenov, Paolo Arosio, Tim Menzen, et al.
Mabs|January 22, 2023
Toward generalizable prediction of antibody thermostability using machine learning on sequence and structure featuresAmeya Harmalkar, Roshan Rao, Yuxuan Richard Xie, et al.
Mabs|November 23, 2022
Non-human primates in the PKPD evaluation of biologics: Needs and options to reduce, refine, and replace. A BioSafe White PaperKarelle Ménochet, Hongbin Yu, Bonnie Wang, et al.
Mabs|June 7, 2021
A human antibody of potent efficacy against SARS-CoV-2 in rhesus macaques showed strong blocking activity to B.1.351Chunyin Gu, Xiaodan Cao, Zongda Wang, et al.
Mabs|November 30, 2022
A glyco-engineering approach for site-specific conjugation to Fab glycansMaria L Jaramillo, Traian Sulea, Yves Durocher, et al.
Pageof 184